Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,411 total articles
Orrstown Financial Services, Inc. announced that it will release its first quarter 2026 earnings report after market close on April 21, 2026. The company will hold a conference call and webcast on April 22, 2026, for management to review the quarterly results with investors and analysts.
Septerna, Inc., a clinical-stage biotech company focused on GPCR drug discovery, has initiated a Phase 1 clinical trial for SEP-479, an oral small molecule PTH1R agonist designed to treat hypoparathyroidism. The trial will assess safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy volunteers, with data expected by late 2026 or e…
Bitcoin Depot announced the hiring of Tony Gagliardi as Chief Compliance Officer to lead and enhance the company's compliance framework amid evolving regulatory requirements. Gagliardi brings over 15 years of experience across financial services and digital assets, overseeing anti-money laundering, Know-Your-Customer programs, and state-level regul…
Howard Hughes Holdings Inc. announced it will release its first quarter 2026 earnings on May 7, 2026, after market close, followed by a conference call on May 8, 2026. The company is a US-based real estate holding company with a portfolio of master planned communities and development projects across multiple US regions.
One Stop Systems, Inc. (NASDAQ: OSS) announced a purchase order exceeding $500,000 from a renewable-energy tech firm developing a network of autonomous energy nodes powering onboard AI compute payloads. This marks the start of a projected multi-year relationship with follow-on orders exceeding $1 million annually, potentially scaling to $10 million…
Jewett-Cameron Trading Company Ltd. released its fiscal 2026 second quarter results showing a 16% increase in revenue driven primarily by liquidation of slow-moving inventory. Despite improved sales, gross margin declined due to selling inventory at or below cost and increased tariff-related expenses. The company is focusing on monetizing non-core …
Pacira BioSciences presented real-world data showing that EXPAREL®, a non-opioid pain therapy, is associated with lower total healthcare costs and reduced opioid utilization in outpatient total hip and knee arthroplasty procedures over multiple follow-up periods. Data highlights include cost savings particularly among Medicare Advantage patients wi…
WEYCO Group, Inc., a global footwear marketer, will announce its Q1 2026 financial results after market close on May 5, 2026, followed by a conference call led by CEO Thomas W. Florsheim, Jr. The company designs and sells footwear mainly for men under several well-known brands and operates both physical and online retail channels.
Microchip Technology has entered a strategic collaboration with Sunny Smartlead to expand the Automotive SerDes Alliance Motion Link (ASA-ML) ecosystem. Sunny Smartlead will introduce ADAS camera modules based on Microchip's VS700 ASA-ML devices, aimed at enabling faster, cost-effective development of secure, high-speed automotive cameras for Softw…
BridgeBio Oncology Therapeutics, a clinical-stage biopharmaceutical firm focusing on RAS-pathway malignancies, announced inducement stock option grants to a newly hired employee as part of its 2025 Inducement Plan. The grant comprises options for 32,675 shares at an $8.40 exercise price, vesting over four years, issued outside of the company's exis…
MainStreet Bancshares, Inc. (Nasdaq: MNSB) announces the promotion of David Murrell to Executive Vice President and Chief Banking Officer. With over 20 years of industry experience, Murrell will lead initiatives to enhance deposit growth and strengthen the bank’s $2.2 billion asset base, focusing on business banking and community leadership in the …
Navitas Semiconductor has appointed Gregory M. Fischer, an experienced semiconductor industry leader and former Broadcom executive, to its Board of Directors. This move supports Navitas's strategic transformation focusing on high-power GaN and silicon carbide technologies, key for AI, energy infrastructure, and industrial electrification sectors. F…
MKS Inc., a global provider of enabling technologies for semiconductor manufacturing and specialty industrial applications, announced its first quarter 2026 financial results release scheduled for after market close on May 6, 2026. The company will host a conference call with management on May 7, 2026, to discuss the results.
Rectitude Holdings Ltd. has secured more than S$10 million in rental and sales contracts for its All-in-One Intelligence Micro-Grid System (AIMS) during the second half of fiscal year 2026, driven by increasing demand for green energy solutions in construction and industrial sectors. The company benefits from Singapore's pro–green energy policies a…
Varonis Systems, Inc., a Nasdaq-listed company specializing in data and AI security, announced it will report its first quarter 2026 financial results on April 28, 2026, after U.S. market close. The company will host a conference call to discuss the results and provide access details. Varonis emphasizes its role in securing AI and critical data, su…
Sana Biotechnology announced a strategic collaboration with Mayo Clinic to advance the development of SC451, an investigational cell replacement therapy designed to potentially cure type 1 diabetes by enabling long-term glucose control without insulin or immunosuppression. Mayo Clinic will standardize clinical protocols and invest equity in Sana, a…
Geron Corporation announced the appointment of Timothy Williams as Executive Vice President, Chief Legal Officer, and Corporate Secretary. Williams brings extensive legal experience in the biopharmaceutical industry, previously serving at Vanda Pharmaceuticals and Stryker Corporation. His addition strengthens Geron's leadership as it advances its c…
Allogene Therapeutics, a clinical-stage biotech company focused on allogeneic CAR T therapies, announced an underwritten public offering of $175 million in common stock, with an option for underwriters to purchase an additional $26.25 million. Proceeds will be used for general corporate purposes including clinical trials, research and development, …
Vertex, Inc., a global leader in tax and compliance technology, announced it will release its first quarter 2026 financial results on May 7, 2026, prior to market open, followed by a conference call at 8:30 a.m. ET. The company provides AI-driven tax automation solutions for enterprises worldwide, aiming to simplify compliance complexity.
Gevo, Inc., a NASDAQ-listed leader in renewable fuels and carbon management, has appointed Joan Cetera as Vice President of Communications and Public Relations. With over 20 years of experience in enterprise communications for public companies, Cetera will oversee Gevo's internal and external communications to support the company's strategic advanc…
Revolution Medicines, a late-stage oncology company targeting RAS-addicted cancers, announced its intention to offer $750 million of common stock and $250 million of convertible senior notes due 2033 in separate public offerings. The company plans to use proceeds for research and development, commercialization expenses, general and administrative c…
3 E Network Technology Group Limited announced a strategic blueprint led by VP Siyang Hu to develop a vertically integrated ecosystem for AI semiconductor and compute infrastructure. The plan includes leveraging both Arm and x86 architectures, focusing on AI all-flash scenarios, and building a full-stack software-hardware-compute center integration…
Celldex Therapeutics announced that its management will present and participate in a fireside chat at the upcoming H.C. Wainwright Inflammatory Skin Disease Virtual Conference. The event will be webcast and replays will be available for 90 days, highlighting Celldex's commitment to advancing novel antibody-based immunology therapies targeting aller…
Dorman Products, Inc. will report its first quarter 2026 financial results after Nasdaq market close on May 4, 2026, with a conference call scheduled for May 5, 2026. The company, a U.S.-based manufacturer of aftermarket automotive replacement products, continues to provide solutions for cars, trucks, and specialty vehicles globally.
NervGen Pharma Corp. (NASDAQ: NGEN), a clinical-stage biopharmaceutical company focused on developing neuroreparative therapeutics for spinal cord injury and other neurological conditions, announced its participation in the H.C. Wainwright HCW@Home series and the 2026 Bloom Burton & Co. Healthcare Investor Conference. The presentations will highlig…
